CuatrecasasP, WilchekM, AnfinsenCB. Selective enzyme purification by affinity chromatography. Proc Natl Acad Sci USA, 1968; 61:636–643; doi: 10.1073/pnas.61.2.636
2.
EngelmannH, NovickD, WallachD. Two tumor necrosis factor-binding proteins purified from human urine: Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem, 1990; 265(3):1531–1536; doi: 10.1016/s0021-9258(19)40049-5
3.
FinkelshteinD, WermanA, NovickD, et al.LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc Natl Acad Sci U S A, 2013; 110(18):7306–7311; doi: 10.1073/pnas.1214441110
4.
LichtensteinDA, SchischlikF, ShaoL, et al.Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells. Blood, 2021; 138(24):2469–2484; doi: 10.1182/blood.2021011898
5.
NovickD. Nine receptors and binding proteins, four drugs, and one woman: Historical and personal perspectives. Front Drug Discov, 2022; 2:1001487; doi: 10.3389/fddsv.2022.1001487
6.
NovickD. A natural goldmine of binding proteins and soluble receptors simplified their translation to blockbuster drugs, all in one decade. Front Immunol, 2023; 14:1151620; doi: 10.3389/fimmu.2023.1151620
7.
NovickD, BarakS, IlanN, et al.Heparanase interacts with resistin and augments its activity. PLoS One, 2014; 9(1):e85944; doi: 10.1371/journal.pone.0085944
8.
NovickD, CohenB, RubinsteinM. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell, 1994; 77(3):391–400; doi: 10.1016/0092-8674(94)90154-6
9.
NovickD, EngelmannH, WallachD, et al.Soluble cytokine receptors are present in normal human urine. J Exp Med, 1989; 170(4):1409–1414; doi: 10.1084/jem.170.4.1409
10.
NovickD, KimSH, FantuzziG, et al.Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity, 1999; 10(1):127–136; doi: 10.1016/s1074-7613(00)80013-8
11.
NovickD, NabioullinRR, RagsdaleW, et al.The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation. J Interferon Cytokine Res, 2000; 20(11):971–982; doi: 10.1089/10799900050198417
12.
NovickD, OrchanskyP, RevelM, et al.The human interferon-gamma receptor: Purification, characterization, and preparation of antibodies. J Biol Chem, 1987; 262(18):8483–8487; doi: 10.1016/S0021-9258(18)47439-X
13.
NovickD, RubinsteinM, AzamT, et al.Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci U S A, 2006; 103(9):3316–3321; doi: 10.1073/pnas.0511206103
14.
NovickD, SchwartsburdB, PinkusR, et al.A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine, 2001; 14(6):334–342; doi: 10.1006/cyto.2001.0914
